Figure 1From: Lipometabolic side-effects of three ritonavir-boosted double protease inhibitor regimens without reverse transcriptase inhibitorsSerum total cholesterol and triglycerides of three double boosted protease inhibitor regimens over 48 weeks.Back to article page